<DOC>
	<DOC>NCT01815099</DOC>
	<brief_summary>We are investigating the feasibility and efficacy of transcranial magnetic stimulation (TMS) for patients with GAD who were placebo nonresponders in DIEF003523.1.</brief_summary>
	<brief_title>Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder</brief_title>
	<detailed_description>We expected to enroll five patients with GAD who failed to respond to a sham (placebo) TMS intervention. In this pilot study we enrolled three participants into a protocol including 10 rTMS sessions (twice a week for five weeks) and one into a protocol including 15 rTMS sessions (three times a week for five weeks). Assessments occurred at pretreatment and at posttreatment.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Participated in the study DIEF003523.1, received sham "placebo" TMS and achieved &lt; 50% improvement in HARS at 3 month followup. Fluency in English Capacity to understand the nature of the study and willingness to sign informed consent form History of epilepsy or head trauma (LOC &gt; 5 minutes) within the past 6 months Lifetime history of increased intracranial pressure, seizure disorder, stroke, brain tumor, multiple sclerosis, or brain surgery A review of patient medications by the study physician indicates an increased risk of seizure An active autoimmune, endocrine, viral, or vascular disorder affecting the brain; any unstable cardiac disease; hypertension; or severe renal or liver insufficiency Substance use disorder or PTSD within the past 6 months Lifetime bipolar disorder, obsessivecompulsive disorder (OCD), psychotic disorder, mental retardation, or pervasive developmental disorder Any psychotic features, including dementia or delirium Concurrent psychotherapy and unwillingness to discontinue Medication change within the past 4 weeks Current serious suicidal or homicidal ideation, and/or serious suicidal attempt within the past 6 months Serious, unstable, or terminal medical condition or clinically judged too psychiatrically unstable to participate in the study Any contraindication for participation in MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>